search
Back to results

A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval (BRAVO-CRT)

Primary Purpose

Heart Failure

Status
Terminated
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
CRT device settings
Sponsored by
University of Minnesota
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure focused on measuring heart failure, CRT, CHF

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of chronic heart failure
  • patients on stable pharmacologic therapy for at least 3 months
  • EF< 35%
  • age >18 years
  • NYHA functional class III or IV
  • eligible for either CRT pacer or CRT defibrillator for heart failure
  • Ischemic or non-ischemic cardiomyopathy
  • patients that are able to tolerate VDD mode with a lower rate of 40bpm programming

Exclusion Criteria:

  • systolic blood pressure <70mmHg
  • Likely to receive a left ventricular assist device or cardiac transplant within 6 months of implant procedure
  • patients who have previously received a CRT device
  • documented atrial fibrillation
  • complete heart block

Sites / Locations

  • University of Minnesota

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

1

2

3

Arm Description

AVD set by taking the larger of 0.50ms or A-V interval 0.30

AVD set by taking the larger of 0.50ms or A-V interval 0.50

AVD set by taking the larger of 0.50ms or A-V interval 0.70

Outcomes

Primary Outcome Measures

To assess the effect of CRT atrioventricular delay settings on biochemical markers in blood through 6 months

Secondary Outcome Measures

assess effects of echocardiogram through 6months after CRT on heart failure
assess the effects of minnesota Living with heart failure questionaire through 6 months after CRT on heart failure
assess effects of six minute hall walk through 6 months after CRt on heart failure
assess effects of SDANN through 6 months after CRT on heart failure

Full Information

First Posted
November 18, 2008
Last Updated
June 22, 2012
Sponsor
University of Minnesota
Collaborators
Minnesota Medical Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00794183
Brief Title
A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval
Acronym
BRAVO-CRT
Official Title
A Pilot Study of theRelationship Between Atrio-Ventricular Delay and Changes in Biochemical Markers of Chronic Heart Failure During Cardiac Resynchronization Therapy (BRAVO-CRT)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2012
Overall Recruitment Status
Terminated
Why Stopped
funding difficulty
Study Start Date
June 2004 (undefined)
Primary Completion Date
May 2010 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota
Collaborators
Minnesota Medical Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The idea of this study is to compare different ways of setting up a pacemaker, using blood tests to give us information about how well it's working. We hope to learn if we can use this approach to figure out the best pacemaker setup ("programming") for each individual patient. The setting we propose to adjust is the timing between the impulse sent between top and bottom chambers.
Detailed Description
There are different kinds of pacemakers and different ways they can be set up to try to make the heart beat regularly. A normal heart has four chambers; these four chambers pump in a co-ordinated way to move blood effectively. When pacemakers were first invented, they told the heart when to pump, but didn't make the four chambers work well together. Newer pacemakers can give more detailed instructions, so the chambers work together more effectively. We already know that the newer (bi-ventricular) pacemakers work better for some patients with heart failure. There are blood tests (often referred to as "markers") that give us information about how well your heart is working and about how your body is responding to heart failure. The idea of this study is to compare different ways of setting up a pacemaker, using these blood tests to give us information about how well it's working. We hope to learn if we can use this approach to figure out the best pacemaker setup ("programming") for each individual patient. Usually pacemakers have two wires or leads, one is in the top right chamber and the other in the bottom right chamber of the heart. The newer pacemakers, which are given to patients with heart failure, have an additional lead or wire, which goes to the left side of the heart. So when heart contracts the lead from top chamber sends impulses to bottom chambers and the leads in right and left sides of bottom chamber responds by sending impulses in a co-ordinated way enabling heart to contract efficiently. Currently, the standard way of treating patients with heart failure is by pacing the top and then bottom chambers, based on a timing interval determined by ultrasound, while also pacing the two bottom chambers in a coordinated manner. There are differences of opinion among experts and by previous studies regarding this method. Pacing is accomplished through pacemaker wires, which are placed in the right top chamber, the right bottom chamber and the left bottom chamber of the heart. The setting we propose to adjust is the timing between the impulse sent between top and bottom chambers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
Keywords
heart failure, CRT, CHF

7. Study Design

Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
AVD set by taking the larger of 0.50ms or A-V interval 0.30
Arm Title
2
Arm Type
Active Comparator
Arm Description
AVD set by taking the larger of 0.50ms or A-V interval 0.50
Arm Title
3
Arm Type
Active Comparator
Arm Description
AVD set by taking the larger of 0.50ms or A-V interval 0.70
Intervention Type
Device
Intervention Name(s)
CRT device settings
Intervention Description
Comparision of A-V delay settings
Primary Outcome Measure Information:
Title
To assess the effect of CRT atrioventricular delay settings on biochemical markers in blood through 6 months
Time Frame
end of the study
Secondary Outcome Measure Information:
Title
assess effects of echocardiogram through 6months after CRT on heart failure
Time Frame
end to study
Title
assess the effects of minnesota Living with heart failure questionaire through 6 months after CRT on heart failure
Time Frame
end of study
Title
assess effects of six minute hall walk through 6 months after CRt on heart failure
Time Frame
end of study
Title
assess effects of SDANN through 6 months after CRT on heart failure
Time Frame
end of study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of chronic heart failure patients on stable pharmacologic therapy for at least 3 months EF< 35% age >18 years NYHA functional class III or IV eligible for either CRT pacer or CRT defibrillator for heart failure Ischemic or non-ischemic cardiomyopathy patients that are able to tolerate VDD mode with a lower rate of 40bpm programming Exclusion Criteria: systolic blood pressure <70mmHg Likely to receive a left ventricular assist device or cardiac transplant within 6 months of implant procedure patients who have previously received a CRT device documented atrial fibrillation complete heart block
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David G Benditt, MD
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States

12. IPD Sharing Statement

Learn more about this trial

A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval

We'll reach out to this number within 24 hrs